Patents Assigned to Bayer
  • Patent number: 7332560
    Abstract: A thermoplastic molding composition comprising polycarbonate and at least one (co)polyformal is disclosed. Characterized by its low water absorption the composition is particularly suitable for producing molded articles, especially optical data carriers, such as compact disks, video disks, digital versatile disks and optical data carriers that are writable and erasable once or repeatedly.
    Type: Grant
    Filed: November 4, 2005
    Date of Patent: February 19, 2008
    Assignee: Bayer MaterialScience AG
    Inventors: Helmut-Werner Heuer, Rolf Wehrmann
  • Patent number: 7332512
    Abstract: The present invention relates to novel halonitrobutadienes, to processes for their preparation and to their use for controlling animal pests.
    Type: Grant
    Filed: October 23, 2002
    Date of Patent: February 19, 2008
    Assignee: Bayer CropScience AG
    Inventors: Reiner Fischer, Peter Jeschke, Angelika Lubos-Erdelen, legal representative, Peter Lösel, Udo Reckmann, Dieter Kaufmann, Viktor Zapolskil, Christoph Erdelen
  • Patent number: 7333195
    Abstract: This invention relates to a method for detecting the photosynthesis-inhibitory activity of substances by providing cells or cell parts with an intact photosystem, introducing the cells or cell parts into a planar layer, applying the test substance to the planar layer or into the planar layer, excitation of the luminescence of the cells or cell parts in the planar layer by an excitation light source, measuring the luminescence of the cells or the cell parts in the planar layer by means of a detector, and associating the detector signal with the degree of photosynthesis inhibition.
    Type: Grant
    Filed: June 26, 2002
    Date of Patent: February 19, 2008
    Assignee: Bayer Innovation GmbH
    Inventors: Wolfgang Kreiβ, Mark Wilhelm Drewes, Günther Eberz, Norbert Caspers
  • Publication number: 20080039432
    Abstract: This invention relates to active compound combinations containing firstly at least one neonicotinoid selected from the group consisting of clothianidin and imidacloprid and secondly at least one cholinesterase inhibitor selected from the group consisting of ethoprophos and aldicarb that are highly suitable for controlling pests, in particular insects and nematodes.
    Type: Application
    Filed: March 26, 2005
    Publication date: February 14, 2008
    Applicant: BAYER CROPSCIENCE AG
    Inventors: Heike Hungenberg, Wolfgang Thielert, Isidro Bailo-Schleiermacher, Christian Nagel, Peter Jeschke
  • Publication number: 20080039481
    Abstract: The use of one or more DMI fungicides from the group consisting of: a) triazoles: a.1. azaconazole, a.2. bitertanol, a.3. bromuconazole, a.4. cyproconazole, a.5. difenoconazole, a.6. diniconazole, a.7. epoxiconazole, a.8. fenbuconazole, a.9. fluquinconazole, a.10. flusilazole, a.11. flutriafol, a.12. hexaconazole, a.13. imibenconazole, a.14. ipconazole, a.15. metconazole, a.16. myclobutanil, a.17. paclobutrazol, a.18. penconazole, a.19. propiconazole, a.20. prothioconazole, a.21. simeconazole, a.22. tebuconazole, a.23. tetraconazole, a.24. triadimenol, a.25. triticonazole; b) pyrimidines: b.1. fenarimol, b.2. nuarimol; c) pyridiness: c.1. pyrifenox; and d) imidazoles: d.1. imazalil, d.2. oxpoconazole fumarate, d.3. peforazoate, d.4. prochloraz, d.5. triflumizole, as seed dressing for soya beans against soya bean rust.
    Type: Application
    Filed: June 7, 2005
    Publication date: February 14, 2008
    Applicant: BAYER CROPSCIENCE AG
    Inventors: Konrad Kemper, Isolde Hauser-Hahn, Paul Reinecke
  • Publication number: 20080039519
    Abstract: The present invention relates to the use of macrocyclic lactones for treating demodicosis, particularly in dogs.
    Type: Application
    Filed: October 27, 2005
    Publication date: February 14, 2008
    Applicant: BAYER HEALTHCARE AG
    Inventors: Josef Heine, Klemens Krieger
  • Publication number: 20080039631
    Abstract: An improved process is described for preparing a N-(substituted arylmethyl)-4-substituted-4-(disubstituted methyl)piperidine of formula (I): wherein R1 and R2 are independently selected from the group consisting of halogen, CF3, OCF3, OCHF2, OCF2CHF2 and SF5; and Z and B are independently selected from the group consisting of CH and N; as well as processes for preparing intermediates useful in the overall process.
    Type: Application
    Filed: September 12, 2005
    Publication date: February 14, 2008
    Applicant: Bayer Crop Science AG
    Inventors: Jaidev Goudar, David Rosen, Walter Yeager, Guozhi Wang, Qun Zhang, Russell Patera
  • Publication number: 20080038247
    Abstract: The invention provides a human GPR39 which is associated with the cardiovascular disorders, endocrine system and hormone disorders, cancer disorders, metabolic diseases, gastrointestinal and liver diseases, hematological disorders, neurological disorders and respiratory diseases. The invention also provides assays for the identification of compounds useful in the treatment or prevention of cardiovascular disorders, endocrine system and hormone disorders, cancer disorders, metabolic diseases, gastrointestinal and liver diseases, hematological disorders, neurological disorders and respiratory diseases. The invention also features compounds which bind to and/or activate or inhibit the activity of GPR39 as well as pharmaceutical compositions comprising such compounds.
    Type: Application
    Filed: April 22, 2004
    Publication date: February 14, 2008
    Applicant: BAYER HEALTHCARE AG
    Inventors: Stefan Golz, Ulf Bruggemeier, Holger Summer, Ralf Thiele
  • Publication number: 20080039446
    Abstract: The invention relates to coagulation of the blood. Disclosed are novel compounds of formula (I), a method for the production of these compounds, pharmaceutical compositions containing them, and methods of using them for the prevention and/or treatment of various diseases.
    Type: Application
    Filed: March 12, 2007
    Publication date: February 14, 2008
    Applicant: Bayer HealthCare AG
    Inventors: Alexander Straub, Thomas Lampe, Jens Pohlmann, Susanne Rohrig, Elisabeth Perzborn, Karl-Heinz Schlemmer
  • Publication number: 20080039663
    Abstract: The invention relates to a novel process for preparing 3-halophthaloyl chlorides (3-halobenzene-1,2-dicarbonyl chlorides) from the corresponding 3-halophthalic anhydrides by reacting with phosgene in the presence of an N,N-dialkylformamide.
    Type: Application
    Filed: November 23, 2005
    Publication date: February 14, 2008
    Applicant: Bayer Corp Science AG
    Inventors: Jorn Stolting, Reinhard Lantzsch, Sergiy Pazenok
  • Patent number: 7329634
    Abstract: The invention relates to novel 3-phenyl-substituted, 3-substituted 4-ketolactams and -lactones of the formula (I) in which Q, W, X, Y, A, B and G are as defined in the disclosure, to processes and intermediates for their preparation and to their use as pesticides and herbicides.
    Type: Grant
    Filed: January 7, 2004
    Date of Patent: February 12, 2008
    Assignee: Bayer CropScience AG
    Inventors: Reiner Fischer, Stefan Lehr, Thomas Bretschneider, Mark Wilhelm Drewes, Dieter Feucht, Jörg Konze, Olga Malsam, Karl-Heinz Kuck, Guido Bojack, Thomas Auler, Martin Hills, Heinz Kehne
  • Patent number: 7329777
    Abstract: This invention relates to methods for treating heart failure, thromboembolic disorders, and pulmonary fibrosis, comprising administering an effective amount of a compound of formula (I) in which the several variables are as defined in the specification and claims.
    Type: Grant
    Filed: August 22, 2005
    Date of Patent: February 12, 2008
    Assignee: Bayer Aktiengesellschaft
    Inventors: Michael Harter, Michael Hahn, Claudia Hirth-Dietrich, Andreas Knorr, Elke Stahl, Johannes-Peter Stasch, Frank Wunder
  • Patent number: 7329633
    Abstract: This invention relates to novel pyrazolylcarboxanilides of formula (I) in which R, R1, R2 and R3 are as defined in the disclosure, to a plurality of processes for preparing these substances and their use for controlling unwanted microorganisms, and to novel intermediates and their preparation.
    Type: Grant
    Filed: February 6, 2003
    Date of Patent: February 12, 2008
    Assignee: Bayer CropScience AG
    Inventors: Ralf Dunkel, Heiko Rieck, Hans-Ludwig Elbe, Ulrike Wachendorff-Neumann, Karl-Heinz Kuck
  • Patent number: 7329670
    Abstract: The compounds are aryl and heteroaryl substituted heterocyclic ureas of the formula A—NH—C(O)—NH—B where A is the aryl or hetaryl substituted heterocyclic group and B is an aryl or heteroaryl moiety. The compounds inhibit raf kinase and are useful in the treatment of RAF kinase mediated diseases.
    Type: Grant
    Filed: December 27, 1999
    Date of Patent: February 12, 2008
    Assignee: Bayer Pharmaceuticals Corporation
    Inventors: Jacques Dumas, Uday Khire, Timothy B. Lowinger, Bernard Riedl, William J. Scott, Roger A. Smith, Jill E. Wood, Holia Hatoum-Mokdad, Jeffrey Johnson, Aniko Redman, Robert Sibley
  • Patent number: 7329717
    Abstract: A process for preparing polyisocyanate-modified polycarboxylic acids by conversion of anhydride-group-free polycarboxylic acids with isocyanate-functional compounds. The process includes reacting A) an anhydride-group-free polycarboxylic-acid component with B) an isocyanate-functional component having an (average) isocyanate functionality of at least 1.8, at an equivalent ratio of carboxylic acid groups to isocyanate groups of from 1.2:1 to 120:1. The polyisocyanate-modified polycarboxylic acids are solid below 40° C. and liquid above 130° C., and have an average carboxylic acid functionality of at least 1.8, a content of free carboxylic acid groups of from 4.0 wt. % to 80.0 wt. % and a content of amide groups of from 0.4 wt. % to 32.5 wt. %.
    Type: Grant
    Filed: June 21, 2004
    Date of Patent: February 12, 2008
    Assignee: Bayer MaterialScience AG
    Inventors: Hans-Josef Laas, Christoph Gürtler, Reinhard Halpaap, Michael Grahl, Peter Thometzek, James Rawlins
  • Patent number: 7329757
    Abstract: The invention relates to novel substituted iminoazines of the general formula (I) in which R1, R2, R3, R4, Z1, Z2 and Z3 are each as defined in the disclosure, to a plurality of processes for their preparation, and to their use as herbicides.
    Type: Grant
    Filed: January 18, 2006
    Date of Patent: February 12, 2008
    Assignee: Bayer Aktiengesellschaft
    Inventors: Klaus-Helmut Muller, Mark Wilhelm Drewes, Peter Dahmen, Dieter Feucht, Rolf Pontzen
  • Patent number: 7329331
    Abstract: An electrolysis cell, suitable for the electrochemical production of chlorine from aqueous solutions of hydrogen chloride. The cell preferably comprises an anode space formed from an anode, an anode frame, and a back wall, the anode frame supporting the anode, and the anode space having an inlet and an outlet for the electrolyte, a cathode space formed from a current collector. The cell further preferably comprises a cathode frame and a back wall, the cathode frame supporting the current collector and the cathode space having an inlet and an outlet for the gas, a gas diffusion electrode arranged between anode and current collector and an cation exchange membrane arranged between anode and gas diffusion electrode, wherein the gas diffusion electrode is fixed on the current collector.
    Type: Grant
    Filed: September 19, 2002
    Date of Patent: February 12, 2008
    Assignee: Bayer MaterialScience AG
    Inventors: Andreas Bulan, Fritz Gestermann, Manfred Marre, Walter Hansen, Michael Groβholz
  • Publication number: 20080029404
    Abstract: Processes for the production of chlorine by multi-stage oxidation, for example, by thermal reaction of hydrogen chloride with oxygen using catalysts or by non-thermal activated reaction of hydrogen chloride with oxygen, in which the gas mixture formed in the reaction, comprising the target products chlorine and water, unreacted hydrogen chloride and oxygen, and possibly other secondary constituents, such as carbon dioxide and nitrogen, (a) is cooled to condense hydrochloric acid as an aqueous solution of hydrogen chloride and (b) the aqueous solution of hydrogen chloride formed is separated from the gas mixture, characterised in that (c) the separated aqueous solution of hydrogen chloride is fed at least partially to an electrochemical oxidation in which at least part of the hydrogen chloride is oxidised to chlorine, (d) the chlorine gas occurring in step d) is optionally added to the gas mixture occurring in step c), (e) the residues of water present in the gas mixture from steps c) and e), in particular by
    Type: Application
    Filed: May 17, 2007
    Publication date: February 7, 2008
    Applicant: Bayer Material Science AG
    Inventors: Rainer Weber, Jurgen Kintrup, Andreas Bulan, Friedhelm Kamper
  • Publication number: 20080033071
    Abstract: The invention relates to the use of light-activated hardenable silicon compositions for the production of thick-walled moulded articles or thick-walled coatings, such as moulds for casting compositions, moulding compositions, sealants, prosthetic moulded articles or casts, formed-in-place gaskets, thick-walled coatings such as conformal coatings and method for production thereof.
    Type: Application
    Filed: July 27, 2005
    Publication date: February 7, 2008
    Applicant: GE Bayer Silicones GmbH & Co. KG
    Inventors: Uwe Irmer, Stefan Rist, Stephan Bosshammer, Markus Putzer, Thomas Naumann
  • Publication number: 20080033017
    Abstract: A composition for control of parasitic insects and acarids, comprising a combination of pyrethroids and chloronicotinyl compounds.
    Type: Application
    Filed: August 27, 2007
    Publication date: February 7, 2008
    Applicant: BAYER HEALTHCARE LLC
    Inventor: Robert Arther